The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Two Percent of Men with Early-Onset Prostate Cancer Harbor Germline Mutations in the BRCA2 Gene
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Cancer Risks in BRCA2 Mutation Carriers
Breast Cancer Linkage Consortium, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,527
Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer
Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D. F., Evans, C., Deacon, J., & Stratton, M. R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.943 · Cited by 873
Self-citationFrank, T. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1480 · Cited by 812
Evidence for a prostate cancer susceptibility locus on the X chromosome.
Xu, J., Meyers, D., Freije, D., Isaacs, S., Wiley, K., Nusskern, D., Ewing, C., Wilkens, E., Bujnovszky, P., Bova, G. S., et al. (1998) · Nature Genetics · doi:10.1038/2477 · Cited by 690
Frank, T. S., Deffenbaugh, A. M., Reid, J. E., Hulick, M., Ward, B. E., Lingenfelter, B., Gumpper, K. L., Scholl, T., Tavtigian, S. V., Pruss, D. R., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.6.1480 · Cited by 558
A candidate prostate cancer susceptibility gene at chromosome 17p
Tavtigian, S. V., Simard, J., Teng, D. H. F., Abtin, V., Baumgard, M., Beck, A., Camp, N. J., Carillo, A. R., Chen, Y., Dayananth, P., et al. (2001) · Nature Genetics · doi:10.1038/84808 · Cited by 557
Germline mutations in the ribonuclease L gene in families showing linkage with HPC1
Carpten, J., Nupponen, N., Isaacs, S., Sood, R., Robbins, C., Xu, J., Faruque, M., Moses, T., Ewing, C., Gillanders, E., et al. (2002) · Nature Genetics · doi:10.1038/ng823 · Cited by 525
Thorlacius, S., Olafsdottir, G., Tryggvadottir, L., Neuhausen, S., Jonasson, J. G., Tavtigian, S. V., Tulinius, H., Ögmundsdottir, H. M., & Eyfjörd, J. E. (1996) · Nature Genetics · doi:10.1038/ng0596-117 · Cited by 525
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Stratton, M. R., Peto, J., Ponder, B. J., & Easton, D. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600008 · Cited by 495
Self-citationVariation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers
Thompson, D., & Easton, D. (2001) · The American Journal of Human Genetics · doi:10.1086/318181 · Cited by 489
Self-citationPredisposing Gene for Early-Onset Prostate Cancer, Localized on Chromosome 1q42.2-43
Berthon, P., Valeri, A., Cohen-Akenine, A., Drelon, E., Paiss, T., Wöhr, G., Latil, A., Millasseau, P., Mellah, I., Cohen, N., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301879 · Cited by 362
Evidence for a Rare Prostate Cancer–Susceptibility Locus at Chromosome 1p36
Gibbs, M., Stanford, J. L., McIndoe, R. A., Jarvik, G. P., Kolb, S., Goode, E. L., Chakrabarti, L., Schuster, E. F., Buckley, V. A., Miller, E. L., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302287 · Cited by 322
High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients.
Jóhannesdóttir, G., Guðmundsson, J., Bergþorsson, J. Þ., Arason, A., Agnarsson, B. A., Eiríksdóttir, G., Johannsson, O. T., Borg, Å., Ingvarsson, S., Easton, D. F., et al. (1996) · PubMed · Cited by 223
Self-citationTranscriptional activation functions in BRCA2
Milner, J., Ponder, B., Hughes-Davies, L., Seltmann, M., & Kouzarides, T. (1997) · Nature · doi:10.1038/386772a0 · Cited by 211
The BRC repeats are conserved in mammalian BRCA2 proteins
Bignell, G. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.1.53 · Cited by 174
Arason, A., Barkardottir, R. B., & Egilsson, V. (1993) · Europe PMC (PubMed Central) · Cited by 119
Genetic predisposition to prostate cancer
Eeles, R. A., the UK Familial Prostate Study Co-ordinating Group, & Collaborators, T. C. U. F. P. C. S. (1999) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500279 · Cited by 68
Self-citationWilkens, E. P., Freije, D., Xu, J., Nusskern, D. R., Suzuki, H., Isaacs, S. D., Wiley, K. E., Bujnovszky, P., Meyers, D. A., Walsh, P. C., et al. (1999) · The Prostate · Cited by 63
The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel
Vazina, A., Baniel, J., Yaacobi, Y., Shtriker, A., Engelstein, D., Leibovitz, I., Zehavi, M., Sidi, A., Ramon, Y., Tischler, T., et al. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1249 · Cited by 61
Cloning, Chromosomal Mapping and Expression Pattern of the Mouse Brca2 Gene
Connor, F., Smith, A. L., Wooster, R., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.2.291 · Cited by 59
Evidence for a Prostate Cancer Susceptibility Locus on the X Chromosome
Xu, J., Meyers, D. A., Freije, D., Isaacs, S. D., Wiley, K. E., Nusskern, D. R., Ewing, C. M., Wilkens, E. P., Bujnovszky, P., Bova, G. S., et al. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)61689-6 · Cited by 46
No germline mutations in the dimerization domain of MXI1 in prostate cancer clusters
Collaborators, T. C. U. F. P. C. S., Edwards, S., Dearnaley, D., Ardern-Jones, A. T., Hamoudi, R., Easton, D., Ford, D., Shearer, R. J., Dowe, A., & Eeles, R. A. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.498 · Cited by 38
Self-citationEdwards, S. M., Kote‐Jarai, Z., Hamoudi, R., & Eeles, R. A. (2001) · Human Mutation · doi:10.1002/humu.7 · Cited by 16
Self-citation
Cited by
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
BRCA1 and BRCA2: 1994 and beyond
Narod, S. A., & Foulkes, W. D. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1431 · Cited by 967
Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins
Prakash, R., Zhang, Y., Feng, W., & Jasin, M. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016600 · Cited by 869
Castro, E., Goh, C., Olmos, D., Saunders, E., Leongamornlert, D., Tymrakiewicz, M., Mahmud, N., Dadaev, T., Govindasami, K., Guy, M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.1882 · Cited by 850
Self-citationMultiple newly identified loci associated with prostate cancer susceptibility
Collaborators, T. U. G. P. C. S., Eeles, R. A., British Association of Urological Surgeons' Section of Oncology, Collaborators, T. U. P. S., Kote-Jarai, Z., Giles, G. G., Olama, A. A. A., Guy, M., Jugurnauth, S. K., Mulholland, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.90 · Cited by 844
Self-citation
Metadata
- Authors
- Edwards, S. M., Kote-Jarai, Z., Meitz, J., Hamoudi, R., Hope, Q., Osin, P., Jackson, R., Southgate, C., Singh, R., Falconer, A., Dearnaley, D. P., Ardern-Jones, A., Murkin, A., Dowe, A., Kelly, J., Williams, S., Oram, R., Stevens, M., Teare, D. M., Bruce Ponder, A. J., Gayther, S. A., Easton, D. F., & Eeles, R. A.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2003-01
- Volume
- 72
- Issue
- 1
- Pages
- 1-12
- ISSN
- 0002-9297 (ISSN-L)
- OpenAlex
- W2009454156
- Cited by
- 366
- References
- 26
- FWCI
- 12.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.